HESTER BIOSCIENCES
Back to Income Statement
|
HESTER BIOSCIENCES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹311 Cr | ₹305 Cr | ₹266 Cr | ₹235 Cr | ₹214 Cr |
What is the latest Revenue of HESTER BIOSCIENCES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹311 Cr |
| Mar2025 | ₹305 Cr |
| Mar2024 | ₹266 Cr |
| Mar2023 | ₹235 Cr |
| Mar2022 | ₹214 Cr |
How is Revenue of HESTER BIOSCIENCES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹311 Cr | 2.15 | |
| Mar2025 | ₹305 Cr | 14.45 | |
| Mar2024 | ₹266 Cr | 13.23 | |
| Mar2023 | ₹235 Cr | 9.65 | |
| Mar2022 | ₹214 Cr | - | |
Compare Revenue of peers of HESTER BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HESTER BIOSCIENCES | ₹2,146.3 Cr | 3.1% | 13.2% | 22.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹474,396.0 Cr | 0.6% | 6% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,990.0 Cr | 1.2% | 10.5% | 7.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,354.0 Cr | -0.4% | 11% | 40.8% | Stock Analytics | |
| CIPLA | ₹116,705.0 Cr | -1.6% | -2.1% | -4.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹94,790.0 Cr | -4.6% | -14.8% | -8.4% | Stock Analytics | |
HESTER BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | 3.1% |
13.2% |
22.3% |
| SENSEX | -0.9% |
-0.4% |
-6.1% |
You may also like the below Video Courses